Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement
Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRush University Medical Center
About this trial
The purpose of this study is to improve pain management for participantswho need osmotic dilators for cervical preparation the day before their second trimester abortion procedure.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Ketorolac
- oral ibuprofen
- Placebo
- Lidocaine HCl 1%
- Saline
Treatment groups
76 Participants
are divided into 2 treatment groupsLocations
1Rush University Medical Center60612, ChicagoIllinois, United States
Sponsors and collaborators
Rush University Medical Center
Lead sponsor
Source ClinicalTrials.gov